PROTEIN DEGRADATION IN P FALCIPARUM
恶性疟原虫中的蛋白质降解
基本信息
- 批准号:3565473
- 负责人:
- 金额:$ 10.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1992-06-30
- 项目状态:已结题
- 来源:
- 关键词:Plasmodium falciparum aminoacid antibody formation antimalarial agents drug design /synthesis /production enzyme linked immunosorbent assay enzyme structure growth /development hemoglobin high performance liquid chromatography host organism interaction human tissue immunochemistry lysosomes monoclonal antibody peptidases proteolysis
项目摘要
The goal of this research project is to elucidate the functions of
parasite proteases in the growth and maturation of the malarial
parasite Plasmodium falciparum. The goal is related to a long-
range objective of developing new antimalarial drugs targeted at
parasite proteases, especially proteases involved in parasite-host
interactions.
The specific aims of this project are 1) to characterize acid and
neutral proteases and to determine their roles in the degradation
of hemoglobin; 2) to determine there roles of ATP-dependent and
ATP-independent non-lysosomal proteolysis in the development of
P.falciparum; 3) to elucidate the site of action of chloroquine; 4)
to determine the roles of proteases in merozoite-host
interactions.
The following hypotheses will be tested:
1. Digestion of host cytosol by malarial parasites involves acid
proteases in the parasite's food vacuole but also involves non-
lysosomal pathways for the degradation of hemoglobin.
2. Chloroquine interferes with the digestion of hemoglobin by
diverting hemin from sequestration into malarial pigment. The
actual inhibitor of parasite growth is free hemin which inhibits
proteolysis.
3. Chloroquine resistance results from mutations which increase
the efficiency of sequestration of hemin into malarial pigment.
4. Surface proteases of merozoite-stage parasites are active
participants in the process of invasion of erythrocytes by
P.falciparum.
Parasite proteases will be purified by HPLC procedures and will
be characterized Cytochemical and immunocytochemical studies
of cellular proteases will be carried out. Proteases will be carried
out. Proteases will be isolated from various morphological states
of the intraerythrocytic parasite.
本研究项目的目的是阐明
疟原虫生长和成熟过程中的寄生虫蛋白酶
恶性疟原虫 目标是一个长期的-
开发新的抗疟药物的范围目标,
寄生虫蛋白酶,特别是寄生虫-宿主蛋白酶,
交互.
该项目的具体目标是:1)表征酸,
中性蛋白酶,并确定其在降解中的作用
2)确定ATP依赖性和
非ATP依赖性非溶酶体蛋白水解在发育中的作用
阐明氯喹的作用部位;
确定裂殖子宿主中蛋白酶的作用,
交互.
将检验以下假设:
1. 疟原虫对宿主胞浆的消化涉及酸
蛋白酶在寄生虫的食物泡,但也涉及非-
用于血红蛋白降解的溶酶体途径。
2. 氯喹干扰血红蛋白的消化,
将氯化血红素从隔离转化为疟疾色素。 的
寄生虫生长的实际抑制剂是游离氯化血红素,其抑制
蛋白水解
3. 氯喹耐药性是由突变引起的,
氯化血红素螯合成疟疾色素的效率。
4. 裂殖子期寄生虫的表面蛋白酶是活跃的
红细胞侵入过程中的参与者,
P.falciparum.
寄生虫蛋白酶将通过HPLC程序纯化,并将
细胞化学和免疫细胞化学研究
将进行细胞蛋白酶的研究。 蛋白酶将被携带
出去 蛋白酶将从各种形态状态中分离出来
红细胞内寄生虫
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L VANDER JAGT其他文献
DAVID L VANDER JAGT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L VANDER JAGT', 18)}}的其他基金
HUMAN ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS
人醛糖还原酶与糖尿病并发症
- 批准号:
3244584 - 财政年份:1992
- 资助金额:
$ 10.04万 - 项目类别:
HUMAN ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS
人醛糖还原酶与糖尿病并发症
- 批准号:
3244585 - 财政年份:1992
- 资助金额:
$ 10.04万 - 项目类别:
HUMAN ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS
人醛糖还原酶与糖尿病并发症
- 批准号:
2142867 - 财政年份:1992
- 资助金额:
$ 10.04万 - 项目类别:
相似海外基金
Establishment of aminoacid transporter directed prostate cancer therapy based on the liquid biopsy
基于液体活检的氨基酸转运蛋白定向前列腺癌治疗的建立
- 批准号:
20K09555 - 财政年份:2020
- 资助金额:
$ 10.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Destribution of vesicular aminoacid transporters during postnatal development in the trigeminal neurons
三叉神经元出生后发育过程中囊泡氨基酸转运蛋白的分布
- 批准号:
24592762 - 财政年份:2012
- 资助金额:
$ 10.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dopaminergic regulation by D-aminoacid oxidase, an enzyme implicated in schizophrenia
D-氨基酸氧化酶(一种与精神分裂症有关的酶)对多巴胺能的调节
- 批准号:
G0801352/1 - 财政年份:2009
- 资助金额:
$ 10.04万 - 项目类别:
Research Grant
Diseases Of Aminoacid Transport: Genetic, Molecular and Biochemical Studies
氨基酸运输疾病:遗传、分子和生化研究
- 批准号:
nhmrc : 402730 - 财政年份:2006
- 资助金额:
$ 10.04万 - 项目类别:
NHMRC Project Grants
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6656505 - 财政年份:2002
- 资助金额:
$ 10.04万 - 项目类别:
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6659279 - 财政年份:2002
- 资助金额:
$ 10.04万 - 项目类别:
L-Aminoacid oxidase, biochemical mechanisms and apoptose induction
L-氨基酸氧化酶、生化机制和细胞凋亡诱导
- 批准号:
5368381 - 财政年份:2002
- 资助金额:
$ 10.04万 - 项目类别:
Research Grants
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6504097 - 财政年份:2001
- 资助金额:
$ 10.04万 - 项目类别:
AMINOACID RESIDUE INVOLVED IN METAL ION BINDING BY CLASS II METALLOTHIONEINS (78)
参与 II 类金属硫蛋白金属离子结合的氨基酸残基 (78)
- 批准号:
6502534 - 财政年份:2001
- 资助金额:
$ 10.04万 - 项目类别:














{{item.name}}会员




